Surmodics | SRDX

Surmodics traded at $17.28 this Friday March 17th, decreasing $1.04 or 5.68 percent since the previous trading session. Looking back, over the last four weeks, Surmodics lost 27.52 percent. Over the last 12 months, its price fell by 59.94 percent. Looking ahead, we forecast Surmodics to be priced at 16.73 by the end of this quarter and at 15.18 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
17.28
Daily Change
-5.68%
Yearly
-59.94%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Abbott 97.01 -2.02 -2.04% -20.78%
Align Technology 320.87 -5.53 -1.69% -27.55%
Anika Therapeutics 26.86 -0.77 -2.79% -4.95%
Arrowhead Research 24.30 -0.14 -0.57% -48.71%
Baxter International 37.58 -0.79 -2.06% -52.50%
BioScrip 31.14 -0.41 -1.30% 17.11%
Boston Scientific 47.95 -0.35 -0.72% 8.44%
Artivion Inc 11.81 -0.45 -3.67% -45.68%
EDAP TMS 10.83 -0.32 -2.87% 48.97%
Edwards Lifesciences 80.74 -1.17 -1.43% -28.40%
Haemonetics 76.61 -1.16 -1.49% 33.75%
Heron Therapeutics 2.32 -0.07 -2.93% -57.82%
J&J 152.38 -1.65 -1.07% -12.85%
Mesa Laboratories 165.48 -3.37 -2.00% -38.09%
Merit Medical Systems 69.56 -1.40 -1.97% 7.61%
Nektar Therapeutics 0.98 -0.14 -12.49% -82.50%
Surmodics 17.28 -1.04 -5.68% -59.94%
Stryker 274.44 -0.77 -0.28% 2.66%
Trinity Biotech 0.87 -0.04 -4.13% -18.47%

Indexes Price Day Year
USND 11631 -86.76 -0.74% -16.29%
US2000 1726 -45.35 -2.56% -17.27%

Surmodics
Surmodics, Inc. is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.